NSE:SOLARA (India)
Â
Ordinary Shares
₹
536.15
-22.65 (-4.05%)
Jul 22
Business Description
Solara Active Pharma Sciences Ltd
ISIN : INE624Z01016
Share Class Description:
NSE:SOLARA: Ordinary SharesTotal Employee Number:
2,924Compare
Compare
Traded in other countries / regions
541540.India IPO Date
2018-06-27Description
Solara Active Pharma Sciences Ltd is engaged in the Active Pharmaceutical Ingredients (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinoid, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant, and others. It also offers contract services, including contract development and manufacturing, and analytical services. Geographically, the company generates all of its revenue from India.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | 0.54 | |||||
Debt-to-Equity | 0.55 | |||||
Debt-to-EBITDA | 3.67 | |||||
Interest Coverage | 0.92 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.22 | |||||
Beneish M-Score | -2.36 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -4.2 | |||||
3-Year EBITDA Growth Rate | 3.4 | |||||
3-Year EPS without NRI Growth Rate | 60.8 | |||||
3-Year FCF Growth Rate | 25.4 | |||||
3-Year Book Growth Rate | -12.2 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 13.82 | |||||
9-Day RSI | 27.1 | |||||
14-Day RSI | 36.48 | |||||
3-1 Month Momentum % | 19.97 | |||||
6-1 Month Momentum % | 9.8 | |||||
12-1 Month Momentum % | -12.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.96 | |||||
Quick Ratio | 0.6 | |||||
Cash Ratio | 0.07 | |||||
Days Inventory | 178.54 | |||||
Days Sales Outstanding | 98.43 | |||||
Days Payable | 144.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.2 | |||||
Shareholder Yield % | -0.25 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 50 | |||||
Operating Margin % | 6.36 | |||||
Net Margin % | -0.54 | |||||
EBITDA Margin % | 13.66 | |||||
FCF Margin % | 7.31 | |||||
OCF Margin % | 11.17 | |||||
ROE % | -0.62 | |||||
ROA % | -0.32 | |||||
ROIC % | 4.12 | |||||
3-Year ROIIC % | -14.83 | |||||
ROC (Joel Greenblatt) % | 5.76 | |||||
ROCE % | 6.31 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 17.8 | |||||
Shiller PE Ratio | 660.64 | |||||
PS Ratio | 1.69 | |||||
PB Ratio | 2.06 | |||||
Price-to-Tangible-Book | 2.98 | |||||
Price-to-Free-Cash-Flow | 23.63 | |||||
Price-to-Operating-Cash-Flow | 15.47 | |||||
EV-to-EBIT | 36.83 | |||||
EV-to-EBITDA | 17.21 | |||||
EV-to-Revenue | 2.35 | |||||
EV-to-FCF | 33.78 | |||||
Price-to-GF-Value | 0.93 | |||||
Price-to-Projected-FCF | 2.78 | |||||
Earnings Yield (Greenblatt) % | 2.71 | |||||
FCF Yield % | 3.87 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Solara Active Pharma Sciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 13,689.8 | ||
| EPS (TTM) (₹) | -1.68 | ||
| Beta | 1.7233 | ||
| 3-Year Sharpe Ratio | 0.42 | ||
| 3-Year Sortino Ratio | 0.75 | ||
| Volatility % | 32.39 | ||
| 14-Day RSI | 36.48 | ||
| 14-Day ATR (₹) | 24.081871 | ||
| 20-Day SMA (₹) | 568.3025 | ||
| 12-1 Month Momentum % | -12.8 | ||
| 52-Week Range (₹) | 422 - 734.4 | ||
| Shares Outstanding (Mil) | 48.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Solara Active Pharma Sciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Solara Active Pharma Sciences Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2026-11-05 15:30 | In 106 days | ||
| Second quarter earnings results for 2027 | 2026-11-05 | In 105 days | ||
| General meeting for 2026 | 2026-09-25 10:30 | In 65 days | ||
| Annual report for 2026 | 2026-09-02 | In 41 days | ||
| First quarter earnings conference call for 2027 | 2026-07-23 16:00 | In 1 day | ||
| First quarter earnings results for 2027 | 2026-07-23 | 558.80 (-1.96%) | ||
| Fourth quarter earnings conference call for 2026 | 2026-05-15 15:00 | 507.70 (+1.27%) | ||
| Fourth quarter earnings results for 2026 | 2026-05-15 | 507.70 (+1.27%) | ||
| Third quarter earnings conference call for 2026 | 2026-02-06 16:30 | 526.45 (-1.96%) | ||
| Third quarter earnings results for 2026 | 2026-02-06 | 526.45 (-1.96%) |
Show
Entries
Solara Active Pharma Sciences Ltd Frequently Asked Questions
What is Solara Active Pharma Sciences Ltd(NSE:SOLARA)'s stock price today?
The current price of NSE:SOLARA is ₹536.15. The 52 week high of NSE:SOLARA is ₹734.40 and 52 week low is ₹422.00.
When is next earnings date of Solara Active Pharma Sciences Ltd(NSE:SOLARA)?
The next earnings date of Solara Active Pharma Sciences Ltd(NSE:SOLARA) is 2026-07-23.
Does Solara Active Pharma Sciences Ltd(NSE:SOLARA) pay dividends? If so, how much?
Solara Active Pharma Sciences Ltd(NSE:SOLARA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Solara Active Pharma Sciences Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers